Your browser doesn't support javascript.
loading
Phase II study of accelerated hypofractionated three-dimensional conformal radiotherapy for stage T1-3 N0 M0 non-small cell lung cancer: NCIC CTG BR.25.
Cheung, Patrick; Faria, Sergio; Ahmed, Shahida; Chabot, Pierre; Greenland, Jonathan; Kurien, Elizabeth; Mohamed, Islam; Wright, James R; Hollenhorst, Helmut; de Metz, Catherine; Campbell, Holly; Vu, Thi Toni; Karvat, Anand; Wai, Elaine S; Ung, Yee C; Goss, Glenwood; Shepherd, Frances A; O'Brien, Patti; Ding, Keyue; O'Callaghan, Chris.
Afiliação
  • Cheung P; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada (PC, YCU); Montreal General Hospital, McGill University, Montreal, Quebec, Canada (SF); CancerCare Manitoba, Winnipeg, Manitoba, Canada (SA); Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada (PC); Dr. H. Bliss Mur
  • Faria S; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada (PC, YCU); Montreal General Hospital, McGill University, Montreal, Quebec, Canada (SF); CancerCare Manitoba, Winnipeg, Manitoba, Canada (SA); Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada (PC); Dr. H. Bliss Mur
  • Ahmed S; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada (PC, YCU); Montreal General Hospital, McGill University, Montreal, Quebec, Canada (SF); CancerCare Manitoba, Winnipeg, Manitoba, Canada (SA); Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada (PC); Dr. H. Bliss Mur
  • Chabot P; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada (PC, YCU); Montreal General Hospital, McGill University, Montreal, Quebec, Canada (SF); CancerCare Manitoba, Winnipeg, Manitoba, Canada (SA); Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada (PC); Dr. H. Bliss Mur
  • Greenland J; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada (PC, YCU); Montreal General Hospital, McGill University, Montreal, Quebec, Canada (SF); CancerCare Manitoba, Winnipeg, Manitoba, Canada (SA); Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada (PC); Dr. H. Bliss Mur
  • Kurien E; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada (PC, YCU); Montreal General Hospital, McGill University, Montreal, Quebec, Canada (SF); CancerCare Manitoba, Winnipeg, Manitoba, Canada (SA); Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada (PC); Dr. H. Bliss Mur
  • Mohamed I; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada (PC, YCU); Montreal General Hospital, McGill University, Montreal, Quebec, Canada (SF); CancerCare Manitoba, Winnipeg, Manitoba, Canada (SA); Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada (PC); Dr. H. Bliss Mur
  • Wright JR; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada (PC, YCU); Montreal General Hospital, McGill University, Montreal, Quebec, Canada (SF); CancerCare Manitoba, Winnipeg, Manitoba, Canada (SA); Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada (PC); Dr. H. Bliss Mur
  • Hollenhorst H; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada (PC, YCU); Montreal General Hospital, McGill University, Montreal, Quebec, Canada (SF); CancerCare Manitoba, Winnipeg, Manitoba, Canada (SA); Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada (PC); Dr. H. Bliss Mur
  • de Metz C; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada (PC, YCU); Montreal General Hospital, McGill University, Montreal, Quebec, Canada (SF); CancerCare Manitoba, Winnipeg, Manitoba, Canada (SA); Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada (PC); Dr. H. Bliss Mur
  • Campbell H; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada (PC, YCU); Montreal General Hospital, McGill University, Montreal, Quebec, Canada (SF); CancerCare Manitoba, Winnipeg, Manitoba, Canada (SA); Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada (PC); Dr. H. Bliss Mur
  • Vu TT; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada (PC, YCU); Montreal General Hospital, McGill University, Montreal, Quebec, Canada (SF); CancerCare Manitoba, Winnipeg, Manitoba, Canada (SA); Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada (PC); Dr. H. Bliss Mur
  • Karvat A; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada (PC, YCU); Montreal General Hospital, McGill University, Montreal, Quebec, Canada (SF); CancerCare Manitoba, Winnipeg, Manitoba, Canada (SA); Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada (PC); Dr. H. Bliss Mur
  • Wai ES; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada (PC, YCU); Montreal General Hospital, McGill University, Montreal, Quebec, Canada (SF); CancerCare Manitoba, Winnipeg, Manitoba, Canada (SA); Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada (PC); Dr. H. Bliss Mur
  • Ung YC; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada (PC, YCU); Montreal General Hospital, McGill University, Montreal, Quebec, Canada (SF); CancerCare Manitoba, Winnipeg, Manitoba, Canada (SA); Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada (PC); Dr. H. Bliss Mur
  • Goss G; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada (PC, YCU); Montreal General Hospital, McGill University, Montreal, Quebec, Canada (SF); CancerCare Manitoba, Winnipeg, Manitoba, Canada (SA); Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada (PC); Dr. H. Bliss Mur
  • Shepherd FA; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada (PC, YCU); Montreal General Hospital, McGill University, Montreal, Quebec, Canada (SF); CancerCare Manitoba, Winnipeg, Manitoba, Canada (SA); Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada (PC); Dr. H. Bliss Mur
  • O'Brien P; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada (PC, YCU); Montreal General Hospital, McGill University, Montreal, Quebec, Canada (SF); CancerCare Manitoba, Winnipeg, Manitoba, Canada (SA); Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada (PC); Dr. H. Bliss Mur
  • Ding K; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada (PC, YCU); Montreal General Hospital, McGill University, Montreal, Quebec, Canada (SF); CancerCare Manitoba, Winnipeg, Manitoba, Canada (SA); Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada (PC); Dr. H. Bliss Mur
  • O'Callaghan C; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada (PC, YCU); Montreal General Hospital, McGill University, Montreal, Quebec, Canada (SF); CancerCare Manitoba, Winnipeg, Manitoba, Canada (SA); Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada (PC); Dr. H. Bliss Mur
J Natl Cancer Inst ; 106(8)2014 Aug.
Article em En | MEDLINE | ID: mdl-25074417
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Ano de publicação: 2014 Tipo de documento: Article